Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide |
Choi, Jung Eun
(Department of Pediatrics, Ewha Womans University School of Medicine)
Kwak, Yujin (Department of Pediatrics, Ewha Womans University School of Medicine) Huh, Jung Won (Department of Laboratory Medicine, Ewha Womans University School of Medicine) Yoo, Eun-Sun (Department of Pediatrics, Ewha Womans University School of Medicine) Ryu, Kyung-Ha (Department of Pediatrics, Ewha Womans University School of Medicine) Sohn, Sejung (Department of Pediatrics, Ewha Womans University School of Medicine) Hong, Young Mi (Department of Pediatrics, Ewha Womans University School of Medicine) |
1 | McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and longterm management of kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017;135:e927-99. DOI |
2 | Kang HR, Kwon YH, Yoo ES, Ryu KH, Kim JY, Kim HS, et al. Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease. Blood Res 2013;48:254-7. DOI |
3 | Mukherjee D, Pal P, Kundu R, Niyogi P. Macrophage activation syn drome in Kawasaki disease. Indian Pediatr 2014;51:148-9. |
4 | Yang SL, Xu XJ, Tang YM, Song H, Xu WQ, Zhao FY, et al. Asso ciations between inflammatory cytokines and organ damage in pedi atric patients with hemophagocytic lymphohistiocytosis. Cytokine 2016;85:14-7. DOI |
5 | Palazzi DL, McClain KL, Kaplan SL. Hemophagocytic syndrome after Kawasaki disease. Pediatr Infect Dis J 2003;22:663-6. |
6 | Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-6. DOI |
7 | Muise A, Tallett SE, Silverman ED. Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome? Pediatrics 2003;112(6 Pt 1):e495. DOI |
8 | al-Eid W, al-Jefri A, Bahabri S, al-Mayouf S. Hemophagocytosis complicating Kawasaki disease. Pediatr Hematol Oncol 2000;17:323-9. DOI |
9 | Kaneko K, Takahashi K, Fujiwara S, Maruyama T, Obinata K. Kawa saki disease followed by haemophagocytic syndrome. Eur J Pediatr 1998;157:610-1. DOI |
10 | Ohga S, Ooshima A, Fukushige J, Ueda K. Histiocytic haemophago cytosis in a patient with Kawasaki disease: changes in the hyper cytokinaemic state. Eur J Pediatr 1995;154:539-41. DOI |
11 | Cummings C, McCarthy P, van Hoff J, Porter G Jr. Kawasaki disease associated with reactive hemophagocytic lymphohistiocytosis. Pediatr Infect Dis J 2008;27:1116-8. DOI |
12 | Titze U, Janka G, Schneider EM, Prall F, Haffner D, Classen CF. Hemophagocytic lymphohistiocytosis and Kawasaki disease: com bined manifestation and differential diagnosis. Pediatr Blood Cancer 2009;53:493-5. DOI |
13 | Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 2009:127-31. |
14 | Demirkol D, Yildizdas D, Bayrakci B, Karapinar B, Kendirli T, Koroglu TF, et al. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunc tion syndrome/macrophage activation syndrome: what is the treat ment? Crit Care 2012;16:R52. DOI |
15 | Lin KH, Chang SS, Yu CW, Lin SC, Liu SC, Chao HY, et al. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a syste matic review and metaanalysis. BMJ Open 2015;5:e006703. DOI |
16 | Sackett K, Cunderlik M, Sahni N, Killeen AA, Olson AP. Extreme Hyperferritinemia: causes and impact on diagnostic reasoning. Am J Clin Pathol 2016;145:646-50. DOI |
17 | Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, SaintCyr C, et al. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol 2009;30:810-7. DOI |
18 | Bae HK, Lee DK, Kwon JH, Kim HS, Sohn S, Hong YM. Clinical characteristics and serum Nterminal probrain natriuretic peptide as a diagnostic marker of Kawasaki disease in infants younger than 3 months of age. Korean J Pediatr 2014;57:357-62. DOI |
19 | Kwon H, Lee JH, Jung JY, Kwak YH, Kim DK, Jung JH, et al. Nter minal probrain natriuretic peptide can be an adjunctive diagnostic marker of hyperacute phase of Kawasaki disease. Eur J Pediatr 2016; 175:19972003. DOI |
20 | Japan Kawasaki Disease Research Committee. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo: Ministry of Health and Welfare, 1984. |
21 | Freeman HR, Ramanan AV. Review of haemophagocytic lympho histiocytosis. Arch Dis Child 2011;96:68893. DOI |
22 | Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH2004: Diagnostic and therapeutic guidelines for hemo phagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31. DOI |
23 | Kleynberg RL, Schiller GJ. Secondary hemophagocytic lympho histiocytosis in adults: an update on diagnosis and therapy. Clin Adv Hematol Oncol 2012;10:726-32. |
24 | Brisse E, Wouters CH, Matthys P. Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities. Br J Haematol 2016;174:203-17. DOI |
25 | Chen Y, Shang S, Zhang C, Liu T, Yang Z, Tang Y. Hemophagocytic lymphohistiocytosis at initiation of kawasaki disease and their differ ential diagnosis. Pediatr Hematol Oncol 2010;27:244-9. DOI |
26 | Inoue S, Mangat C, Rafe'e Y, Sharman M. Forme Fruste of HLH (hae mophagocytic lymphohistiocytosis): diagnostic and therapeutic challenges. BMJ Case Rep 2015 Jan 29;2015. pii: bcr2014206190. https://doi.org/10.1136/bcr2014206190. |
27 | Sung L, King SM, Carcao M, Trebo M, Weitzman SS. Adverse outcomes in primary hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 2002;24:550-4. DOI |
28 | Karapinar B, Yilmaz D, Balkan C, Akin M, Ay Y, Kvakli K. An unusual cause of multiple organ dysfunction syndrome in the pediatric inten sive care unit: hemophagocytic lymphohistiocytosis. Pediatr Crit Care Med 2009;10:285-90. DOI |
29 | Beutel G, Wiesner O, Eder M, Hafer C, Schneider AS, Kielstein JT, et al. Virusassociated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection. Crit Care 2011;15:R80. DOI |
30 | Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lan cet Infect Dis 2007;7:814-22. DOI |
![]() |